Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lucentis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lucentis was produced by Novartis and Roche.

NICE backs Bayer's Eylea in diabetic eye condition

NICE backs Bayer's Eylea in diabetic eye condition The guidance will give Eylea a boost at a time when Bayer is looking to close the gap between its drug and Lucentis - and will give it a fillip after

Novartis launches Apple Watch app for the visually impaired

Novartis launches Apple Watch app for the visually impaired development. Novartis' eye-care interests centre around its Alcon division and its Wet AMD treatment Lucentis (ranibizumab) and its efforts to go 'beyond the pill' and develop additional digital health services

NICE no for new eye disease drug

NICE no for new eye disease drug drugs on the market, including Novartis/Roche's Lucentis (ranibizumab) and Bayer/Regeneron's Eylea (aflibercept).

Eylea growth closes the gap with Lucentis

Eylea growth closes the gap with Lucentis Armed with new indications such as diabetic macular edema (DME), Eylea (aflibercept) can now compete with rival Lucentis (ranibizumab) sold by Roche and Novartis on a more equal footing and sales ... Lucentis still selling more than Eylea by value but is

Medius Deal Watch table for February 2015

Medius Deal Watch table for February 2015 Majority acquisition. 380. Pfenex/ Hospira. PF582 - LUCENTIS biosimilar candidate - wet age-related macular degeneration, diabetic macular oedema.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...